Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CACNA1B antisense RNA 2 (CACNA1B-AS2)
- Target
- CACNA1B-AS2
- Molecular classification
- Long non-coding RNA (lncRNA)
01
Overview
CACNA1B-AS2 is a long non-coding RNA (lncRNA) gene located antisense to the protein-coding CACNA1B locus. This gene does not encode a protein and is not classified as a receptor, ion channel, enzyme, or transporter. Its biological function is uncharacterized; while antisense RNAs may play regulatory roles on their sense counterparts (such as modulating mRNA stability or transcription), no specific function or disease association has been established for CACNA1B-AS2 itself. It is not considered a therapeutic target, and no drugs or biomarkers are linked to it[5].
- Other names
- CACNA1B-AS2
02
Mechanism of action
Not applicable; no drugs or modulators target CACNA1B-AS2
03
Biological functions
Unknown; as an antisense RNA, potential regulatory roles on CACNA1B gene expression, but specific functions have not been described in the literature
04
Disease associations
None clearly established for CACNA1B-AS2; disease association data is available for the protein-coding CACNA1B gene but not specifically for CACNA1B-AS2
05
Safety considerations
None known; not a therapeutic target
06
Interacting drugs
None
07
Biomarkers
None; not used for patient selection or efficacy monitoring
Beyond the preview
Go deeper on CACNA1B antisense RNA 2 (CACNA1B-AS2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CACNA1B antisense RNA 2 (CACNA1B-AS2).